Logo image of ADUS

ADDUS HOMECARE CORP (ADUS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ADUS - US0067391062 - Common Stock

113.19 USD
-0.97 (-0.85%)
Last: 12/5/2025, 8:02:07 PM
113.19 USD
0 (0%)
After Hours: 12/5/2025, 8:02:07 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ADUS. ADUS was compared to 100 industry peers in the Health Care Providers & Services industry. While ADUS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ADUS has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ADUS was profitable.
In the past year ADUS had a positive cash flow from operations.
In the past 5 years ADUS has always been profitable.
ADUS had a positive operating cash flow in each of the past 5 years.
ADUS Yearly Net Income VS EBIT VS OCF VS FCFADUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

With an excellent Return On Assets value of 6.02%, ADUS belongs to the best of the industry, outperforming 85.15% of the companies in the same industry.
The Return On Equity of ADUS (8.16%) is better than 68.32% of its industry peers.
ADUS has a Return On Invested Capital of 7.35%. This is in the better half of the industry: ADUS outperforms 69.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADUS is below the industry average of 9.42%.
The 3 year average ROIC (7.23%) for ADUS is below the current ROIC(7.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.02%
ROE 8.16%
ROIC 7.35%
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ADUS Yearly ROA, ROE, ROICADUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

ADUS has a better Profit Margin (6.36%) than 83.17% of its industry peers.
ADUS's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 9.15%, ADUS is doing good in the industry, outperforming 76.24% of the companies in the same industry.
In the last couple of years the Operating Margin of ADUS has grown nicely.
ADUS has a better Gross Margin (32.66%) than 61.39% of its industry peers.
ADUS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.15%
PM (TTM) 6.36%
GM 32.66%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
ADUS Yearly Profit, Operating, Gross MarginsADUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ADUS is destroying value.
The number of shares outstanding for ADUS has been increased compared to 1 year ago.
The number of shares outstanding for ADUS has been increased compared to 5 years ago.
The debt/assets ratio for ADUS is higher compared to a year ago.
ADUS Yearly Shares OutstandingADUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADUS Yearly Total Debt VS Total AssetsADUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

ADUS has an Altman-Z score of 5.12. This indicates that ADUS is financially healthy and has little risk of bankruptcy at the moment.
ADUS has a Altman-Z score of 5.12. This is amongst the best in the industry. ADUS outperforms 87.13% of its industry peers.
ADUS has a debt to FCF ratio of 1.56. This is a very positive value and a sign of high solvency as it would only need 1.56 years to pay back of all of its debts.
ADUS has a better Debt to FCF ratio (1.56) than 87.13% of its industry peers.
ADUS has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ADUS (0.14) is better than 73.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.56
Altman-Z 5.12
ROIC/WACC0.86
WACC8.58%
ADUS Yearly LT Debt VS Equity VS FCFADUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

ADUS has a Current Ratio of 1.66. This is a normal value and indicates that ADUS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.66, ADUS is in the better half of the industry, outperforming 62.38% of the companies in the same industry.
ADUS has a Quick Ratio of 1.66. This is a normal value and indicates that ADUS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.66, ADUS is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.66
ADUS Yearly Current Assets VS Current LiabilitesADUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

ADUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.93%, which is quite good.
ADUS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.61% yearly.
ADUS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.77%.
Measured over the past years, ADUS shows a quite strong growth in Revenue. The Revenue has been growing by 12.22% on average per year.
EPS 1Y (TTM)12.93%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%20%
Revenue 1Y (TTM)18.77%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%25.02%

3.2 Future

The Earnings Per Share is expected to grow by 10.72% on average over the next years. This is quite good.
ADUS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.83% yearly.
EPS Next Y19.1%
EPS Next 2Y14.83%
EPS Next 3Y12.53%
EPS Next 5Y10.72%
Revenue Next Year23.63%
Revenue Next 2Y15.08%
Revenue Next 3Y11.6%
Revenue Next 5Y8.83%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ADUS Yearly Revenue VS EstimatesADUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
ADUS Yearly EPS VS EstimatesADUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.35, ADUS is valued on the expensive side.
Based on the Price/Earnings ratio, ADUS is valued a bit cheaper than 72.28% of the companies in the same industry.
When comparing the Price/Earnings ratio of ADUS to the average of the S&P500 Index (26.49), we can say ADUS is valued slightly cheaper.
A Price/Forward Earnings ratio of 16.38 indicates a correct valuation of ADUS.
ADUS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ADUS is cheaper than 70.30% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.69. ADUS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.35
Fwd PE 16.38
ADUS Price Earnings VS Forward Price EarningsADUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ADUS's Enterprise Value to EBITDA ratio is in line with the industry average.
ADUS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ADUS is cheaper than 60.40% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.7
EV/EBITDA 15.43
ADUS Per share dataADUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

ADUS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ADUS has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ADUS's earnings are expected to grow with 12.53% in the coming years.
PEG (NY)1.01
PEG (5Y)1.16
EPS Next 2Y14.83%
EPS Next 3Y12.53%

0

5. Dividend

5.1 Amount

No dividends for ADUS!.
Industry RankSector Rank
Dividend Yield N/A

ADDUS HOMECARE CORP

NASDAQ:ADUS (12/5/2025, 8:02:07 PM)

After market: 113.19 0 (0%)

113.19

-0.97 (-0.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners104.23%
Inst Owner Change-1.28%
Ins Owners2.39%
Ins Owner Change0.28%
Market Cap2.09B
Revenue(TTM)1.35B
Net Income(TTM)85.65M
Analysts83.16
Price Target144.33 (27.51%)
Short Float %3.77%
Short Ratio4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.43%
Min EPS beat(2)-0.58%
Max EPS beat(2)-0.28%
EPS beat(4)2
Avg EPS beat(4)1.02%
Min EPS beat(4)-0.58%
Max EPS beat(4)4.43%
EPS beat(8)5
Avg EPS beat(8)3.95%
EPS beat(12)9
Avg EPS beat(12)5.2%
EPS beat(16)12
Avg EPS beat(16)4.17%
Revenue beat(2)1
Avg Revenue beat(2)-0.47%
Min Revenue beat(2)-1.14%
Max Revenue beat(2)0.2%
Revenue beat(4)1
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)0.2%
Revenue beat(8)1
Avg Revenue beat(8)-1.19%
Revenue beat(12)1
Avg Revenue beat(12)-1.14%
Revenue beat(16)1
Avg Revenue beat(16)-1.49%
PT rev (1m)-0.29%
PT rev (3m)0.48%
EPS NQ rev (1m)-0.39%
EPS NQ rev (3m)1.09%
EPS NY rev (1m)0.64%
EPS NY rev (3m)0.94%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)1.9%
Revenue NY rev (1m)0.98%
Revenue NY rev (3m)0.98%
Valuation
Industry RankSector Rank
PE 19.35
Fwd PE 16.38
P/S 1.55
P/FCF 21.7
P/OCF 20.28
P/B 1.99
P/tB N/A
EV/EBITDA 15.43
EPS(TTM)5.85
EY5.17%
EPS(NY)6.91
Fwd EY6.1%
FCF(TTM)5.22
FCFY4.61%
OCF(TTM)5.58
OCFY4.93%
SpS72.87
BVpS56.82
TBVpS-2.33
PEG (NY)1.01
PEG (5Y)1.16
Graham Number86.48
Profitability
Industry RankSector Rank
ROA 6.02%
ROE 8.16%
ROCE 9.73%
ROIC 7.35%
ROICexc 7.99%
ROICexgc 130.52%
OM 9.15%
PM (TTM) 6.36%
GM 32.66%
FCFM 7.16%
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ROICexc(3y)7.89%
ROICexc(5y)7.67%
ROICexgc(3y)101.25%
ROICexgc(5y)84.78%
ROCE(3y)9.58%
ROCE(5y)8.86%
ROICexgc growth 3Y20.44%
ROICexgc growth 5Y33.14%
ROICexc growth 3Y-5.68%
ROICexc growth 5Y3.17%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
F-Score4
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.56
Debt/EBITDA 1.09
Cap/Depr 43.63%
Cap/Sales 0.5%
Interest Coverage 10.45
Cash Conversion 74.36%
Profit Quality 112.56%
Current Ratio 1.66
Quick Ratio 1.66
Altman-Z 5.12
F-Score4
WACC8.58%
ROIC/WACC0.86
Cap/Depr(3y)56.89%
Cap/Depr(5y)51.78%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.74%
Profit Quality(3y)174.92%
Profit Quality(5y)182.39%
High Growth Momentum
Growth
EPS 1Y (TTM)12.93%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%20%
EPS Next Y19.1%
EPS Next 2Y14.83%
EPS Next 3Y12.53%
EPS Next 5Y10.72%
Revenue 1Y (TTM)18.77%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%25.02%
Revenue Next Year23.63%
Revenue Next 2Y15.08%
Revenue Next 3Y11.6%
Revenue Next 5Y8.83%
EBIT growth 1Y20.42%
EBIT growth 3Y13.7%
EBIT growth 5Y25.34%
EBIT Next Year45.83%
EBIT Next 3Y19.04%
EBIT Next 5Y14.43%
FCF growth 1Y-0.53%
FCF growth 3Y46.87%
FCF growth 5Y71.69%
OCF growth 1Y-3.13%
OCF growth 3Y43.4%
OCF growth 5Y57.54%

ADDUS HOMECARE CORP / ADUS FAQ

Can you provide the ChartMill fundamental rating for ADDUS HOMECARE CORP?

ChartMill assigns a fundamental rating of 6 / 10 to ADUS.


Can you provide the valuation status for ADDUS HOMECARE CORP?

ChartMill assigns a valuation rating of 6 / 10 to ADDUS HOMECARE CORP (ADUS). This can be considered as Fairly Valued.


How profitable is ADDUS HOMECARE CORP (ADUS) stock?

ADDUS HOMECARE CORP (ADUS) has a profitability rating of 8 / 10.


Can you provide the financial health for ADUS stock?

The financial health rating of ADDUS HOMECARE CORP (ADUS) is 6 / 10.


What is the earnings growth outlook for ADDUS HOMECARE CORP?

The Earnings per Share (EPS) of ADDUS HOMECARE CORP (ADUS) is expected to grow by 19.1% in the next year.